These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 18063667)

  • 1. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
    Dideberg V; Kristjansdottir G; Milani L; Libioulle C; Sigurdsson S; Louis E; Wiman AC; Vermeire S; Rutgeerts P; Belaiche J; Franchimont D; Van Gossum A; Bours V; Syvänen AC
    Hum Mol Genet; 2007 Dec; 16(24):3008-16. PubMed ID: 17881657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
    Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
    Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
    Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
    Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
    Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
    Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
    Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.
    Hu W; Ren H
    Int J Immunogenet; 2011 Oct; 38(5):411-7. PubMed ID: 21834935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis.
    Rueda B; Reddy MV; González-Gay MA; Balsa A; Pascual-Salcedo D; Petersson IF; Eimon A; Paira S; Scherbarth HR; Pons-Estel BA; González-Escribano MF; Alarcón-Riquelme ME; Martín J
    Arthritis Rheum; 2006 Dec; 54(12):3815-9. PubMed ID: 17133578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
    Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; de la Serna AR; Fernandez-Gutierrez B; Castañeda S; Largo R; Joven B; Narvaez J; Navarro F; Marenco JL; Vicario JL; Blanco FJ; Fernandez-Lopez JC; Caliz R; Collado-Escobar MD; Carreño L; Lopez-Longo J; Cañete JD; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2008 May; 58(5):1264-74. PubMed ID: 18438842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction.
    Mälarstig A; Sigurdsson S; Eriksson P; Paulsson-Berne G; Hedin U; Wallentin L; Siegbahn A; Hamsten A; Syvänen AC
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):975-82. PubMed ID: 18323517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics and biology of Irf5-mediated signaling in lupus.
    Kozyrev SV; Alarcon-Riquelme ME
    Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus.
    Myouzen K; Kochi Y; Shimane K; Fujio K; Okamura T; Okada Y; Suzuki A; Atsumi T; Ito S; Takada K; Mimori A; Ikegawa S; Yamada R; Nakamura Y; Yamamoto K
    Hum Mol Genet; 2010 Jun; 19(11):2313-20. PubMed ID: 20194224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.
    Yin H; Borghi MO; Delgado-Vega AM; Tincani A; Meroni PL; Alarcón-Riquelme ME
    Arthritis Rheum; 2009 Aug; 60(8):2468-71. PubMed ID: 19644876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells.
    Löfgren SE; Yin H; Delgado-Vega AM; Sanchez E; Lewén S; Pons-Estel BA; Witte T; D'Alfonso S; Ortego-Centeno N; Martin J; Alarcón-Riquelme ME; Kozyrev SV
    J Rheumatol; 2010 Mar; 37(3):574-8. PubMed ID: 20080916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.